The FDA Review Division has determined that there does not appear to be a need for an advisory committee meeting at this time for the New Drug Application (NDA) for DCCR (diazoxide choline) ...
From stealing records to shutting down emergency rooms, cyberattacks are impacting more Connecticut residents amid new a push for health-care cybersecurity.